AWHP submitted a testimony respectfully urging that coverage for obesity treatment in state-regulated commercial insurance and Medicaid be included in the in the State Fiscal Year 2025-26 Executive Budget.

AWHP submitted comments to the Centers for Medicare & Medicaid Services (CMS) on their recent proposal to expand coverage for obesity medications in Medicare Part D and Medicaid.

AWHP provided comments on the USPSTF’s draft guidelines on screening for cervical cancer.

AWHP submitted comments on WPSI’s draft recommendations on screening and counseling for intimate partner violence, breast cancer screening, and patient navigation services for breast and cervical cancer.

AWHP sent letters to the White House Initiative on Women’s Health Research, Senate Appropriations Committee, and House Appropriations committee urging modest additional funding for the USPSTF.

AWHP sent a letter to the Connecticut Department of Social Services urging the immediate implementation of Public Act 23-94, which establishes coverage for obesity medications and weight-loss surgery through the state’s Medicaid program.

AWHP submitted comments to the CDC’s ACIP expressing its support of lowering the age recommendation for HPV vaccination to 9.

AWHP sent a letter to the House Committee on Energy and Commerce urging their action in support for expanding access to obesity care by prioritizing the passage of the amended version of the Treat and Reduce Obesity Act.

AWHP wrote a letter to the Senate Committee on Finance encouraging the passage of the amended version of TROA.